5 Antimetastatic Therapy Page 1 5 Antimetastatic Therapy NICOLE S. AMATO* Ethos
Veterinary Health, Woburn, Massachusetts, USA Introduction The ability of cancer cells to …

Advancements in oncology have resulted in significant improvement in clinical outputs for
cancer patients. However, Cancer recurrence after initial therapeutic response remains a …

Osteosarcoma (OS) is an aggressive mesenchymal cell tumor that carries a poor long-term
prognosis. Despite definitive surgery for the primary tumor and adjuvant chemotherapy …

Cancer immunotherapy has made breakthrough progress in cancer treatment. However,
only a subset of patients benefits from immunotherapy. Given their unique structure …

Lung cancer's mortality is predominantly linked to post-chemotherapy recurrence, driven by
the reactivation of dormant cancer cells. Despite the critical role of these reactivated cells in …

Dysregulation of Fibroblast Growth Factor Receptors (FGFRs) signaling has been
associated with breast cancer, yet employing FGFR-targeted delivery systems to improve the …

Solid tumors metastasize very early in their development, and once the metastatic cell is
lodged in a remote organ, it can proliferate to generate a metastatic lesion or remain …

Background: Prostate cancer (PCa) is known to exhibit a wide spectrum of aggressiveness
and relatively high immunogenicity. The aim of this study was to examine the effect of tumor …

Melatonin is a multifunctional hormone regulator that maintains homeostasis through
circadian rhythms, and desynchronization of these rhythms can lead to gastrointestinal …

摘要术后无症状的早期癌症(肺癌) 患者的转移靶器官中已经潜伏有处于休眠状态的播散肿瘤
细胞(DTCs), 其增殖是导致临床转移发生的关键环节. 开发维持DTCs 休眠或根除休眠DTCs …